TET2 mutations contribute to adverse prognosis in acute myeloid leukemia (AML): results from a comprehensive analysis of 502 AML cases and the Beat AML public database
2024 · Clinical and Experimental Medicine · 18 citations
https://doi.org/10.1007/s10238-024-01297-0